Table 3.

Treatment Received at Progression (n=38)^*

Stopped Dalteparin at First Progression (n=16)
Treatment Received
None Reported	15
Other**	1
Continued Dalteparin at First Progression (n=22)***
Treatment Received
None Reported	3
Temozolomide alone	4
Temozolomide, BCNU, Vincristine,other**	1
Temozolomide, BCNU	1
Temozolomide, CPT11, other**	3
Temozolomide, Thalidomide, CPT11	1
Temozolomide, Thalidomide	1
Temozolomide, other **	5
Other**	3

^*2 patients did not progress and 2 patients stopped dalteparin at least 7 weeks before progression and are excluded.

^**“Other” includes surgery, hydroxyurea, tarceva, radiation

^***Four of these 22 continued dalteparin until the 2^nd or 3^rd progression of their disease and are counted as such in Table 2.